Effects of angiotensin II and captopril on rewarding propreties of morphine

Indian Journal of Experimental Biology

Volumn 45, Issue 9, 2007, Pages 770-777

  Hosseini, Mahmoud ^a   Sharifi, Mohammad Reza ^b   Alaei, Hojatallah ^b   Shafei, Mohammad Naser ^a   Karimooy, Habib Allah Nemati ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angiotensin II; Captopril; CPP; Morphine; Rat; Self administration

Indexed keywords

RATTUS; RATTUS NORVEGICUS;

ANGIOTENSIN II; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MORPHINE;

ANIMAL; ARTICLE; CONDITIONING; DRUG EFFECT; DRUG SELF ADMINISTRATION; MALE; PHYSIOLOGY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REWARD; WISTAR RAT;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPTOPRIL; CONDITIONING (PSYCHOLOGY); MALE; MORPHINE; RATS; RATS, WISTAR; RENIN-ANGIOTENSIN SYSTEM; REWARD; SELF ADMINISTRATION;

EID: 35748952514     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Diana M, Muntoni AL, Pistis M, Melis M & Gessa G L, Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal, Eur J Neurosci, 11 (1999) 1037.
2. Wang H L, Zhao Y, Xiang X H, Wang H S & Wu W R, Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats, Prog Neuropsychopharmacol Biol Psychiatry, 28 (2004) 1079.
3. Winnicka M M & Wisniewski K, Disruption of temporoentorhinal connections abolishes the facilitatory effect of angiotensins on memory in rats, Pharmacol Res, 40 (1999) 53.
4. Winnicka M M, 6-OHDA bilateral lesions to the amygdala abolish the memory enhancing effect of angiotensin II in rats, Pharmacol.Res, 38 (1998) 53.
5. Allen A M, Mac Gregor D P, McKinley M J & Mendelsohn F A, Angiotensin II receptors in the human brain, Regul Pept, 79 (1999) 1.
6. Savaskan E, The role of the brain renin-angiotensin system in neurodegenerative disorders, Curr.Alzheimer Res, 2 (2005) 29.
7. Winnicka M M, Dopaminergic projection to the nucleus accumbens mediates the memory-enhancing effect of angiotensins in rats, Pharmacol Biochem Behav, 62 (1999) 625.
8. Georgiev V P, Lazarova M B & Kambourova T S, Further evidence for the interactions between angiotensin II and GABAergic transmission in pentylenetetrazol kindling seizures in mice, Neuropeptides, 28 (1995) 29.
9. Kulakowska A, Karwowska W, Wisniewski K & Braszko J J, Losartan influences behavioural effects of angiotensin II in rats, Pharmacol Res, 134 (996)109.
10. Raghavendra V, Chopra K & Kulkarni S K, Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory, Neuropeptides, 32 (1998) 417.
11. Gard P R, The role of angiotensin II in cognition and behaviour, Eur.J.Pharmacol, 438 (2002) 1.
12. Barnes JM, Barnes N M & Costall B, Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition, Brain Res, 507 (1990) 341.
13. Han N L, Luo F, Bian Z P & Han J S, Synergistic effect of cholecystokinin octapeptide and angiotensin II in reversal of morphine induced analgesia in rats, Pain, 85 (2000) 465.
14. Tchekalarova J, Pechlivanova D, Kambourova T, Matsoukas J& Georgiev V, The effects of sarmesin, an Angiotensin II analogue on seizure susceptibility, memory retention and nociception, Regul.Pept, 111 (2003), 191.
15. Jenkins TA, Mendelsohn FA & Chai SY, Angiotensinconverting enzyme modulates dopamine turnover in the striatum, J.Neurochem, 68 (1997) 1304.
16. Kaada B & Woie L, Effects of an angiotensin converting enzyme (ACE) inhibitor on plasma endorphin level, Gen Pharmacol, 21 (1990) 693.
17. Reardon K A, Mendelsohn F A, Chai S Y & Horne M K, The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson's disease, Aust N Z J Med, 30 (2000) 48.
18. Nikolova J G, Getova D P & Nikolov F P, Effects of ACEinhibitors on learning and memory processes in rats, Folia Med (Plovdiv.), 42(2000) 47.
19. Raghavendra V, Chopra K & Kulkarni S K, Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm, Neuropeptides, 35(2001) 65.
20. Giardina W J & Ebert D M, Positive effects of captopril in the behavioral despair swim test, Biol Psychiatry, 25 (1989) 697.
21. Martin P, Massol J & Puech A J, Captopril as an antidepressant? Effects on the learned helplessness paradigm in rats, Biol Psychiatry 27 (1990) 968.
22. Alaei H, Esmaeili M, Nasimi A & Pourshanazari A, Ascorbic acid decreases morphine self-administration and withdrawal symptoms in rats, Pathophysiology, 12 (2005) 103.
23. Sahraei H, Poorheidari G, Foadaddini M, Khoshbaten A, Asgari A, Noroozzadeh A, Ghoshooni H, Firoozabadi S H, & Zarrindast M R, Effects of nitric oxide on morphine selfadministration in rat, Pharmacol Biochem Behav, 77 (2004) 111.
24. Paxinos G &Watson C, The rat brain etreotaxic coordinates (Academic Press, San Diego) 1998.
25. Kim S Y, Chudapongse N, Lee S M, Levin M C, Oh J T, Park H J & Ho I K, Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains, Brain Res.Mol Brain Res, 133 (2005) 58.
26. Rajaei Z, Alaei H, Nasimi A, Amini H & Ahmadiani A, Ascorbate reduces morphine-induced extracellular DOPAC level in the nucleus accumbens: A microdialysis study in rats, Brain Res, 1053 (2005) 62.
27. Gupta Y K, Chugh A, Arora S & Seth S D, Modulation of morphine induced antinociception by intracerebroventricularly administered captopril, Indian J Exp Biol, 29 (1991)543.
28. Takai S, Song K, Tanaka T, Okunishi H & Miyazaki M, Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice, Life Sci, 59 (1996) L331.
29. Shvarts G I & Faermark I F, Experimental study of the effect of captopril on pain reactions, Biull Eksp Biol Med, 102 (1986) 575.
30. Das S, Chatterjee T K & Ghosh J J, Adrenal involvement in captopril-induced potentiation of morphine analgesia, Eur J Pharmacol, 85 (1982) 217.
31. Varon J & Duncan S R, Naloxone reversal of hypotension due to captopril overdose, Ann Emerg Med, 20(1991) 1125.
32. Lal J & Atkinson J, Involvement of the renin-angiotensin system in the dipsogenic effect of morphine, Arch Int Pharmacodyn Ther, 278 (1985) 273.
33. Koyuncuoglu H, Hatipoglu I & Enginar N, The effect of morphine, naloxone, D- and L-aspartic acid on the brain and lung ACE in mice, Pharmacol Res Commun, 15 (1983) 969.
34. Koyuncuoglu H, Gungor M, Enginar N, Hatipoglu I & Hizal A, Brain asparaginase, ACE activity and plasma cortisol level in morphine dependent rats: effect of aspartic acid and naloxone, Pharmacol Biochem Behav, 25 (1986) 953.
35. Melzig M F, Heder G, Siems W E & Zipper J, Stimulation of endothelial angiotensin-converting enzyme by morphine via non-opioid receptor mediated processes, Pharmazie 53(1998) 634.
36. Handa K, Sasaki J, Tanaka H, Kiyonaga A, Matsunaga A, Shindo M & Arakawa K, Effects of captopril on opioid peptides during exercise and quality of life in normal subjects, Am Heart J, 122 (1991) 1389.
37. Szczepanska R, Harding S & Grupp L A, Characterization of the decline in alcohol consumption by aminopeptidase inhibition, Drug Alcohol Depend, 43 (1996) 133.
38. Irazusta J, Larrinaga G, Agirregoitia N, Varona A & Casis L, Effects of morphine administration and its withdrawal on rat brain aminopeptidase activities, Regul .Pept, 110 (2003) 225.
39. Sudakov S K, Figurina I B, Medvedeva O F & Rusakova I V, Effect of substance P on intravenous self-administration of morphine in different rat strains, Bull Exp Biol Med, 132 (2001) 923.
40. Dumont E C, Rafrafi S, Laforest S & Drolet G, Involvement of central angiotensin receptors in stress adaptation, Neuroscience, 93 (1999) 877.
41. McNally G P & Akil H, Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal Neuroscience, 112 (2002) 605.
42. Van Ree J M & Niesink R J, Pituitary-adrenal axis and oral morphine consumption in rats, Pharmacol.Biochem.Behav, 9(1978) 493.
43. Kolesnikov Y A, Pick C G & Pasternak G W, NG-nitro-Larginine prevents morphine tolerance, Eur J Pharmacol, 221(1992) 399.
44. Kimes A S, Vaupel D B & London E D, Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase, Psychopharmacology (Berl) 112 (1993) 521.
45. Krizanova O, Kiss A, Zacikova L & Jezova D, Nitric oxide synthase mRNA levels correlate with gene expression of angiotensin II type-1 but not type-2 receptors, renin or angiotensin converting enzyme in selected brain areas, Physiol Res, 50 (2001) 473.